Assignee
ANTIGEN EXPRESS INC
US·8 granted patents·5 pending applications·150 citations·filing 1993–2014
Top patents by PatentIndex Score
13 records- 0191US7179645B2Ii-Key/antigenic epitope hybrid peptide vaccinesANTIGEN EXPRESS INC·Filed 2002·Granted Feb 20, 2007·54 cites·8 claims
- 0287US7935350B2Ii-key/Her-2/neu hybrid cancer vaccineANTIGEN EXPRESS INC·Filed 2007·Granted May 3, 2011·4 cites·4 claims
- 0382US7541334B2Hybrid peptides modulate the immune responseANTIGEN EXPRESS INC·Filed 2007·Granted Jun 2, 2009·3 cites·1 claims
- 0478US5559028AMethods of enhancing or antigen presentation to T cells inhibitingANTIGEN EXPRESS INC·Filed 1993·Granted Sep 24, 1996·37 cites·3 claims
- 0577US7205274B2Hybrid peptides modulate the immune responseANTIGEN EXPRESS INC·Filed 2002·Granted Apr 17, 2007·6 cites·3 claims
- 0671US6432409B1Hybrid peptides modulate the immune responseANTIGEN EXPRESS INC·Filed 1999·Granted Aug 13, 2002·24 cites·6 claims
- 0764US2015093402A1Ii-KEY/HER-2/NEU HYBRID CANCER VACCINEANTIGEN EXPRESS INC·Filed 2014·Application pending·0 cites
- 0856US6368855B1MHC class II antigen presenting cells containing oligonucleotides which inhibit Ii protein expressionANTIGEN EXPRESS INC·Filed 1998·Granted Apr 9, 2002·11 cites·39 claims
- 0955US2008305122A1Ii-Key/antigenic epitope hybrid peptide vaccinesANTIGEN EXPRESS INC·Filed 2007·Application pending·0 cites
- 1052US5679527AModification of polypeptide structureANTIGEN EXPRESS INC·Filed 1994·Granted Oct 21, 1997·11 cites·1 claims
- 1149US2003235594A1Ii-Key/antigenic epitope hybrid peptide vaccinesANTIGEN EXPRESS INC·Filed 2002·Application pending·0 cites
- 1248US2003198626A1Inhibition of Ii expression in mammalian cellsANTIGEN EXPRESS INC·Filed 2002·Application pending·0 cites
- 1346US2003054365A1MHC class II antigen presenting cells containing oligonucleotides which inhibit Ii protein expressionANTIGEN EXPRESS INC·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ANTIGEN EXPRESS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →